Frontiers in Oncology is delighted to present the ‘Clinical Trials, Practice, and Design in…’ series of article collections.
Clinical Trials, Practice, and Design in Skin Cancer will publish high-quality articles that report clinical trials or clinical studies on original or updated data, including retrospective observational studies, and comprehensive literature reviews of clinical trials in Skin Cancer. We also welcome submissions that cover the design and conduct of clinical trials.
The Topic Editors are specifically interested in submissions on, but not limited to, the following themes:
1. Quantification of Cutaneous Cancer Burden in Clinical Trials
2. Abscopal effects
3. Diagnostics
4. Clinical Trials Response Assessment
5. Cutaneous immune response AEs
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Frontiers in Oncology is delighted to present the ‘Clinical Trials, Practice, and Design in…’ series of article collections.
Clinical Trials, Practice, and Design in Skin Cancer will publish high-quality articles that report clinical trials or clinical studies on original or updated data, including retrospective observational studies, and comprehensive literature reviews of clinical trials in Skin Cancer. We also welcome submissions that cover the design and conduct of clinical trials.
The Topic Editors are specifically interested in submissions on, but not limited to, the following themes:
1. Quantification of Cutaneous Cancer Burden in Clinical Trials
2. Abscopal effects
3. Diagnostics
4. Clinical Trials Response Assessment
5. Cutaneous immune response AEs
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.